<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:DOC-5NR1KCHZ</identifier><date>1992</date><creator>Čufer, Tanja</creator><relation>documents/doc/5/URN_NBN_SI_doc-5NR1KCHZ_001.pdf</relation><relation>documents/doc/5/URN_NBN_SI_doc-5NR1KCHZ_001.txt</relation><format format_type="type">article</format><format format_type="extent">Str. 5</format><identifier identifier_type="COBISSID_HOST">804825</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-5NR1KCHZ</identifier><language>slv</language><publisher>Onkološki inštitut</publisher><source>Rak sečnega mehurja</source><rights>InC</rights><subject language_type_id="slv">Antineoplastic agents</subject><subject language_type_id="slv">Bladder neoplasms</subject><subject language_type_id="slv">Epidemiology</subject><subject language_type_id="slv">Neoplasm staging</subject><subject language_type_id="slv">Pathology</subject><title>Rak sečnega mehurja</title></Record>